Literature DB >> 7194615

Response of babesiosis to pentamidine therapy.

P B Francioli, J S Keithly, T C Jones, R D Brandstetter, D J Wolf.   

Abstract

Three nonsplenectomized patients were infected with Babesia microti. One had fever, abdominal pain suggesting gallbladder disease, and evidence of disseminated intravascular coagulation; another was considered to have lymphoma, partly because two smears for Babesia before admission were negative. All three patients were treated with pentamidine isethionate and improved clinically. Parasites were no longer seen on smears after 5 days of therapy, but Babesia could still be recovered by hamster inoculation 5 weeks after therapy in one of the patients tested, underscoring the need for this test to properly evaluate eradication of the organism. In one patient, pentamidine was stopped after 7 days because of increased creatinine concentration, and this amount of drug appeared adequate to control the parasitemia. Pain at drug injection sites was a major side effect in all three patients. Pentamidine appears to be useful in controlling clinical manifestations of babesiosis and decreasing parasitemia, but it does not eradicate the organism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7194615     DOI: 10.7326/0003-4819-94-3-326

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Babesiosis in California.

Authors:  A F Jerant; A D Arline
Journal:  West J Med       Date:  1993-06

2.  Babesiosis: under-reporting or case-clustering?

Authors:  C S Clarke; E T Rogers; E L Egan
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

3.  Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity.

Authors:  C A Bell; M Cory; T A Fairley; J E Hall; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 4.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.